Previous Article | Next Article ![]()
Journal of Virology, March 1999, p. 1785-1794, Vol. 73, No. 3
Departments of
Virology,1
Chemistry,2 and
Macromolecular
Structure,3 Bristol-Myers Squibb
Pharmaceutical Research Institute, Wallingford, Connecticut 06492
Received 31 August 1998/Accepted 1 December 1998
The hemagglutinin (HA) protein undergoes a low-pH-induced
conformational change in the acidic milieu of the endosome, resulting in fusion of viral and cellular membranes. A class of compounds that
specifically interact with the HA protein of H1 and H2 subtype viruses and inhibit this conformational change was recently described (G. X. Luo et al., Virology 226:66-76, 1996, and J. Virol.
71:4062-4070, 1997). In this study, purified HA trimers
(bromelain-cleaved HA [BHA]) are used to examine the properties and
binding characteristics of these inhibitors. Compounds were able to
inhibit the low-pH-induced change of isolated trimers, as detected by
resistance to digestion with trypsin. Protection from digestion was
extremely stable, as BHA-inhibitor complexes could be incubated for
24 h in low pH with almost no change in BHA structure. One
inhibitor was prepared as a radiolabeled photoaffinity analog and used
to probe for specific drug interactions with the HA protein. Analysis
of BHA after photoaffinity analog binding and UV cross-linking revealed
that the HA2 subunit of the HA was specifically radiolabeled.
Cross-linking of the photoaffinity analog to BHA under neutral (native)
pH conditions identified a stretch of amino acids within the
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
pH-Dependent Changes in Photoaffinity Labeling
Patterns of the H1 Influenza Virus Hemagglutinin by Using an
Inhibitor of Viral Fusion
-helix
of HA2 that interact with the inhibitor. Interestingly, cross-linking of the analog under acidic conditions identified a different region within the HA2 N terminus which interacts with the photoaffinity compound. These attachment sites help to delineate a potential binding
pocket and suggest a model whereby the BHA is able to undergo a
partial, reversible structural change in the presence of inhibitor compound.
*
Corresponding author. Mailing address: Department of
Virology, Bristol-Myers Squibb Pharmaceutical Research Institute, 5 Research Pkwy., Wallingford, CT 06492. Phone: (203) 677-7974. Fax:
(203) 677-6088. E-mail: krystalm{at}bms.com.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|